Scintigraphic imaging and turnover studies with iodine-131 labelled serum amyloid P component in systemic amyloidosis

被引：0
|
作者：
Hawkins, P.N. [1 ]
Aprile, C. [2 ,5 ]
Capri, G. [3 ]
Vigano, L. [3 ]
Munzone, E. [3 ]
Gianni, L. [3 ]
Pepys, M.B. [1 ]
Merlini, G. [4 ]
机构：
[1] Immunological Medicine Unit, Royal Postgraduate Medical School, Hammersmith Hospital, London, United Kingdom
[2] Nuclear Medicine Service, Scientific Institute Fondazione Maugeri, Pavia, Italy
[3] Division of Medical Oncology, Istituto Nazionale Tumori, Milan, Italy
[4] Biotechnology Research Laboratories, University Hospital S. Matteo, Pavia, Italy
[5] Fond. S.Maugeri- Nuclear Med. Serv., 8,v.Ferrata, I- 27100 Pavia, Italy
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 1998年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
19
引用
收藏
页码：701 / 708
相关论文
共 50 条
  • [11] Serum amyloid P component scintigraphy in AL amyloidosis
    Gillmore, JD
    Persey, MR
    Lovat, LB
    Madhoo, S
    Pepys, MB
    Hawkins, PN
    AMYLOID AND AMYLOIDOSIS 1998, 1999, : 148 - 150
  • [12] SERUM AMYLOID P-COMPONENT PREVENTS PROTEOLYSIS OF THE AMYLOID FIBRILS OF ALZHEIMER-DISEASE AND SYSTEMIC AMYLOIDOSIS
    TENNENT, GA
    LOVAT, LB
    PEPYS, MB
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (10) : 4299 - 4303
  • [13] 99mTc-labelled serum amyloid P component as a tool for evaluating novel amyloid imaging agents
    Wall, J. S.
    Richey, T.
    Hawkins, P. N.
    Solomon, A.
    Kennel, S. J.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2010, 17 : 140 - 141
  • [14] FACTORS INFLUENCING DEXTRAN-GEL FILTRATION OF SERUM AND IODINE-131 LABELLED L-THYROXINE
    CLARK, F
    GOLDSTEIN, G
    CRISPELL, KR
    JOURNAL OF NUCLEAR MEDICINE, 1966, 7 (06) : 464 - +
  • [15] Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis
    Hawkins, PN
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2002, 11 (06): : 649 - 655
  • [16] Serum amyloid P component enhances induction of murine amyloidosis
    Togashi, S
    Lim, SK
    Kawano, H
    Ito, S
    Ishihara, T
    Okada, Y
    Nakano, S
    Kinoshita, T
    Horie, K
    Episkopou, V
    Gottesman, ME
    Costantini, F
    Shimada, K
    Maeda, S
    LABORATORY INVESTIGATION, 1997, 77 (05) : 525 - 531
  • [17] Potential for imaging cerebral amyloid deposits using I-123-labelled serum amyloid P component and SPET
    Bornebroek, M
    Verzijlbergen, JF
    Haan, J
    VanScheyen, EJ
    Verhoeff, NPLG
    Pauwels, EKJ
    Roos, RAC
    NUCLEAR MEDICINE COMMUNICATIONS, 1996, 17 (11) : 929 - 933
  • [18] EVALUATION OF SYSTEMIC AMYLOIDOSIS BY SCINTIGRAPHY WITH I-123 LABELED SERUM AMYLOID-P COMPONENT
    HAWKINS, PN
    LAVENDER, JP
    PEPYS, MB
    NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (08): : 508 - 513
  • [19] The liver in systemic amyloidosis: Insights from I-123-serum amyloid P component scintigraphy
    Lovat, LB
    Persey, MR
    Madhoo, S
    Pepys, ME
    Hawkins, PN
    GASTROENTEROLOGY, 1997, 112 (04) : A1324 - A1324
  • [20] IODINE-123-LABELED SERUM AMYLOID-P COMPONENT SCINTIGRAPHY IN HEMODIALYSIS-ASSOCIATED AMYLOIDOSIS
    FLIPO, RM
    DEVEAUX, M
    DUNETON, O
    FOISSACGEGOUX, P
    DUMONT, A
    DUQUESNOY, B
    MARCHANDISE, X
    NEPHROLOGIE, 1995, 16 (06): : 419 - 425
12345